A PHASE I/II STUDY OF NERATINIB IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID TUMORS OR HEMATOLOGIC MALIGNANCIES

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Langevin, Anne-Marie R

Funded by

SLOAN -KETTERING INSTITUTE FOR CANCER RE

Research Start Date

05/01/2018

Status

Active

Collaborative Project

Clinical Care

Drug Discovery

Cancer

Bioscience Research Panel